Releases
26109 items
Releases
Beijing Expo Debuts AI Zone as Global Supply Chains Converge

Releases
Global Tech Giants and Startups Converge at 4th CISCE in Beijing

Releases
Group 1 Automotive Rebrands Owings Mills Honda Dealership

Releases
Toyota of Bowie Rebrands as Group 1 Toyota Bowie

Releases
RADIN Health Scales AI Radiology Platform Across Nevada UHS Hospitals

Releases
Aircastle Sets July 9 Date for First Quarter 2026 Earnings

Releases
BioLab Holdings Secures AATB Tissue Banking Accreditation

Releases
Documentary Ferocious Drummers Set for Festival Premiere

Releases
Global Display Market Projected to Hit $137.83 Billion by 2032

Releases
Group 1 Automotive Rebrands Landover Hills Dealership

Releases
Infrastructure Capital Raises Dividends Across Key Income ETFs

Releases
Group 1 Rebrands Landover Hills Collision Center

Releases
Hivelocity Targets Healthcare Sector with HIPAA-Ready Bare Metal Suite

Releases
Dermatologist-Backed Skincare Ousts Luxury Giants in AI Search Rankings

Releases
Five Global Institutions Awarded 2026 EBSCO Solar Grants

Releases
Footprints Floors Launches $10,000 Home Remodeling Giveaway

Releases
Eight Libraries Honored with 2026 John Cotton Dana Awards

Releases
STIIIZY Data Breach Settlement Offers Up to $7,500 in Compensation

Releases
Neuro-Restoration Funding Set to Reach $435.9 Million by 2036

Releases
AI Diagnostics Market Poised to Hit $9.7 Billion by 2033
.jpg)
Releases
Global NLP Market Projected to Reach $250 Billion by 2031
Releases
Republic Finance to be Acquired by J.C. Flowers-Led Group

Releases
Elea and AXIA Launch Amazon's First AI Data Center in Belém

Releases
Avantis Investors Hits $150 Billion Milestone in Under Seven Years

Releases
BoomerangFX and Web Marketing Clinic Partner to Scale AI in Europe

Releases
BoomerangFX expands European reach through Web Marketing Clinic partnership

Releases
BoomerangFX and Web Marketing Clinic Partner to Scale AI in Aesthetics

Releases
Anivive Secures Full FDA Approval for Canine Lymphoma Drug Laverdia

Releases
Curis Expands TakeAim CLL Study Sites and Secures Reverse Split Approval

Releases